Glycomet Trio 2 Tablet

Composition

Glimepiride 2 mg + Metformin Hydrochloride (SR) 500 mg + Pioglitazone 15 mg

Uses of Glycomet Trio 2 Tablet

Type 2 diabetes mellitus in adults when diet and exercise alone or dual therapy is inadequate; helps control blood sugar levels and improves glycaemic control.

• •Lowers fasting and post-meal blood glucose
• •Improves insulin sensitivity and reduces insulin resistance
• •Helps achieve better HbA1c control than dual therapy
• •Convenient triple-drug regimen in one tablet
• •May reduce diabetes-related complications by improving glycaemic control

How it works

Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Pioglitazone (a thiazolidinedione) improves insulin sensitivity in muscle and fat by activating PPAR-γ, thereby reducing insulin resistance.

Directions for use

Tablet (oral). Take exactly as prescribed by the doctor, usually once daily with/after the first main meal to reduce stomach upset and risk of low sugar. Swallow whole; do not crush/chew the SR tablet. Monitor blood glucose regularly and follow diet/exercise advice.

Side effects

Common side effects of Glycomet Trio 2 Tablet may include:

• •Hypoglycaemia
• •nausea
• •